Journal
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
Volume 48, Issue 6, Pages 873-892Publisher
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10928-021-09777-6
Keywords
Medication adherence; Missed doses; Levothyroxine; Stochastics
Categories
Funding
- National Science Foundation [DMS-1944574, DMS-1814832]
Ask authors/readers for more resources
This study focuses on medication adherence of patients with chronic diseases, analyzing drug concentration statistics using a mathematical model. The findings suggest that for drugs with long half-life, taking double doses following missed doses may be the best way to mitigate nonadherence. Additionally, the study investigates different ways of handling missed doses and discusses the results in the context of hypothyroid patients taking levothyroxine.
Medication adherence is a major problem for patients with chronic diseases that require long term pharmacotherapy. Many unanswered questions surround adherence, including how adherence rates translate into treatment efficacy and how missed doses of medication should be handled. To address these questions, we formulate and analyze a mathematical model of the drug concentration in a patient with imperfect adherence. We find exact formulas for drug concentration statistics, including the mean, the coefficient of variation, and the deviation from perfect adherence. We determine how adherence rates translate into drug concentrations, and how this depends on the drug half-life, the dosing interval, and how missed doses are handled. While clinical recommendations require extensive validation and should depend on drug and patient specifics, as a general principle our theory suggests that nonadherence is best mitigated by taking double doses following missed doses if the drug has a long half-life. This conclusion contradicts some existing recommendations that cite long drug half-lives as the reason to avoid a double dose after a missed dose. Furthermore, we show that a patient who takes double doses after missed doses can have at most only slightly more drug in their body than a perfectly adherent patient if the drug half-life is long. We also investigate other ways of handling missed doses, including taking an extra fractional dose following a missed dose. We discuss our results in the context of hypothyroid patients taking levothyroxine.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available